(6ar-trans)-isomer of tetrahydrocannabivarin 9 has been researched along with cp-55,940 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bräse, S; Gläser, F; Müller, CE; Nieger, M; Rempel, V; Volz, N | 1 |
| Belardo, C; Cannazza, G; Citti, C; Forni, F; Gigli, G; Laganà, A; Linciano, P; Luongo, L; Maione, S; Montone, CM; Vandelli, MA | 1 |
| Sampson, PB | 1 |
3 other study(ies) available for (6ar-trans)-isomer of tetrahydrocannabivarin 9 and cp-55,940
| Article | Year |
|---|---|
Antagonists for the orphan G-protein-coupled receptor GPR55 based on a coumarin scaffold.
Topics: Allosteric Site; Animals; CHO Cells; Coumarins; Cricetinae; HEK293 Cells; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Structure-Activity Relationship | 2013 |
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal
Topics: Analgesics; Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Medical Marijuana; Mice; Molecular Structure; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2020 |
Phytocannabinoid Pharmacology: Medicinal Properties of
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Endocannabinoids; Humans; Phytochemicals; Signal Transduction | 2021 |